Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer Page 1

Appointment adds biotech veteran with more than two decades of business development, strategy and operational experience to Cidara’s management team

SAN DIEGO, Aug. 19, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients with serious diseases, today announced that Jim Beitel, MBA, has joined the company as Chief Business Officer (“CBO”).